Detalles de la búsqueda
1.
Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study.
Invest New Drugs
; 41(1): 122-133, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36637703
2.
Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy.
BMJ Open
; 13(9): e071500, 2023 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37709306
3.
Development and validation of a new liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of afatinib, dacomitinib, osimertinib, and the active metabolites of osimertinib in human serum.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1199: 123245, 2022 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35436724
Resultados
1 -
3
de 3
1
Próxima >
>>